The following link is only for those interested in the current desperate state of antibiotic research. The article concerns Pfizers layoff of american scientists, due to relocation of their antibacterials unit to China.
AstraZeneca is mentioned as being one of only two major pharmas presently, with strong and active antibiotics research programs.
PYC (not mentioned in article) are presently in a antibiotic research collaboration with Medimmune (AstraZeneca subsidiary).
Cheers ST
http://pharmalive.com/News/Index.cfm?articleid=770638
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |